| Primary |
| Gastrooesophageal Reflux Disease |
30.5% |
| Gastrointestinal Motility Disorder |
9.3% |
| Constipation |
8.0% |
| Impaired Gastric Emptying |
4.9% |
| Hypertension |
4.6% |
| Pain |
4.6% |
| Gastrointestinal Disorder |
4.0% |
| Medical Diet |
3.7% |
| Abdominal Pain |
3.3% |
| Depression |
3.0% |
| Nausea |
2.8% |
| Anxiety |
2.8% |
| Insomnia |
2.8% |
| Osteoporosis |
2.8% |
| Multiple Allergies |
2.6% |
| Asthma |
2.5% |
| Product Used For Unknown Indication |
2.2% |
| Headache |
2.1% |
| Pyrexia |
1.9% |
| Hypothyroidism |
1.7% |
|
| Electrocardiogram Qt Prolonged |
71.6% |
| Electrocardiogram Qt Corrected Interval Prolonged |
3.6% |
| Suicide Attempt |
3.4% |
| Death |
2.5% |
| Atrial Fibrillation |
2.2% |
| Lung Neoplasm Malignant |
2.0% |
| Vomiting |
1.7% |
| Completed Suicide |
1.5% |
| Respiratory Failure |
1.5% |
| Ventricular Extrasystoles |
1.4% |
| Hypokalaemia |
1.2% |
| Pneumonia |
1.2% |
| Diarrhoea |
1.0% |
| Electrolyte Imbalance |
0.8% |
| Spinal Fusion Surgery |
0.8% |
| Urinary Tract Infection |
0.8% |
| Sepsis |
0.7% |
| Supraventricular Tachycardia |
0.7% |
| Transaminases Increased |
0.7% |
| Ventricular Tachycardia |
0.7% |
|
| Secondary |
| Gastrooesophageal Reflux Disease |
36.9% |
| Gastrointestinal Motility Disorder |
25.4% |
| Constipation |
4.5% |
| Depression |
3.8% |
| Osteoporosis |
3.7% |
| Impaired Gastric Emptying |
3.4% |
| Anxiety |
3.0% |
| Hypertension |
2.1% |
| Headache |
1.9% |
| Pain |
1.8% |
| Medical Diet |
1.8% |
| Asthma |
1.4% |
| Abdominal Pain |
1.4% |
| Osteoporosis Prophylaxis |
1.4% |
| Diarrhoea |
1.3% |
| Multiple Allergies |
1.3% |
| Nausea |
1.3% |
| Vitiligo |
1.2% |
| Arthritis |
1.2% |
| Gastrointestinal Disorder |
1.2% |
|
| Electrocardiogram Qt Prolonged |
81.5% |
| Electrocardiogram Qt Corrected Interval Prolonged |
2.8% |
| Suicide Attempt |
2.3% |
| Atrial Fibrillation |
1.8% |
| Respiratory Failure |
1.1% |
| Vomiting |
1.0% |
| Lung Neoplasm Malignant |
1.0% |
| Completed Suicide |
0.9% |
| Death |
0.8% |
| Urinary Tract Infection |
0.8% |
| Ventricular Extrasystoles |
0.8% |
| Hypokalaemia |
0.7% |
| Pneumonia |
0.7% |
| Thyroiditis Subacute |
0.7% |
| Torsade De Pointes |
0.7% |
| Diarrhoea |
0.6% |
| Intentional Overdose |
0.6% |
| Small Intestinal Obstruction |
0.6% |
| Dehydration |
0.5% |
| Electrolyte Imbalance |
0.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
13.2% |
| Drug Use For Unknown Indication |
12.5% |
| Gastrooesophageal Reflux Disease |
8.3% |
| Hypertension |
8.3% |
| Pain |
6.9% |
| Constipation |
6.3% |
| Gastritis Erosive |
5.6% |
| Faeces Discoloured |
4.9% |
| Hiatus Hernia |
4.9% |
| Diabetes Mellitus |
3.5% |
| Central Venous Catheterisation |
2.8% |
| Convulsion |
2.8% |
| Gastritis |
2.8% |
| Hyperlipidaemia |
2.8% |
| Lower Respiratory Tract Infection |
2.8% |
| Nuclear Magnetic Resonance Imaging Abdominal |
2.8% |
| Nuclear Magnetic Resonance Imaging Brain |
2.8% |
| Ankylosing Spondylitis |
2.1% |
| Gastrointestinal Motility Disorder |
2.1% |
| Immunosuppressant Drug Therapy |
2.1% |
|
| Weight Increased |
15.8% |
| Wheelchair User |
10.5% |
| Klebsiella Infection |
7.9% |
| Peritoneal Dialysis Complication |
7.9% |
| Vasculitis |
7.9% |
| Hyperkalaemia |
5.3% |
| Loss Of Consciousness |
5.3% |
| Pancreatitis Necrotising |
5.3% |
| Upper Respiratory Tract Infection |
5.3% |
| Akathisia |
2.6% |
| Apnoea |
2.6% |
| Blood Potassium Decreased |
2.6% |
| Cardiac Disorder |
2.6% |
| Coma |
2.6% |
| Dyskinesia |
2.6% |
| Dyspnoea |
2.6% |
| General Physical Health Deterioration |
2.6% |
| Hepatitis |
2.6% |
| Hepatitis Toxic |
2.6% |
| Humerus Fracture |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.8% |
| Torsade De Pointes |
11.3% |
| Haematoma Infection |
9.7% |
| Gastrooesophageal Reflux Disease |
6.5% |
| Abdominal Pain Upper |
4.8% |
| Bladder Disorder |
4.8% |
| Dyspepsia |
4.0% |
| Prophylaxis Of Nausea And Vomiting |
3.2% |
| Hypokalaemia |
1.6% |
| Hypomagnesaemia |
1.6% |
| Anaesthesia |
0.8% |
| Meningitis Cryptococcal |
0.8% |
|
| Weight Increased |
46.2% |
| Torsade De Pointes |
23.1% |
| Drug Interaction |
15.4% |
| Electrocardiogram Qt Prolonged |
7.7% |
| Overdose |
7.7% |
|
